ABBV vs SNDK: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Sandisk Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Sandisk Corporation · Technology
$1,614.39
-25.3% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
ABBV has more upside to fair value
(-1.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
SNDK |
| Current Price |
$261.70 |
$1,614.39 |
| Fair Value Estimate |
$259.04 |
$1,206.72 |
| Upside to Fair Value |
-1.0%
|
-25.3%
|
| Market Cap |
$462.4B |
$239.1B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
17.9x
|
| Price / Sales |
7.2x
|
11.8x
|
| Price / FCF |
23.6x
|
20.6x
|
| Revenue Growth YoY |
+10.2%
|
+371.6%
|
| Gross Margin |
71.5%
|
71.5%
|
| Operating Margin |
29.3%
|
61.2%
|
| Return on Equity |
-136.5%
|
93.1%
|
| Dividend Yield |
2.61% |
0% |
| FCF Yield |
4.25%
|
4.84%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Sandisk designs and manufactures NAND flash storage solutions, including SSDs, embedded memory, removable cards, USB devices, and wafers, employing roughly 11,100 people from its Milpitas, California headquarters. The business is currently generating extraordinary profitability, with TTM gross margin of 71.5%, operating margin of 61.2%, net margin of 56.5%, and ROE of 93.1%, while revenue grew 37…
Accumulation Zones
| Metric |
ABBV |
SNDK |
| Zone Low |
$194.28 |
$905.04 |
| Zone High |
$220.18 |
$1,025.71 |
| In Buy Zone? |
No
|
No
|